TickerFacts.

Tenaya Therapeutics, Inc. (TNYA): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$68.88M
Year ended 2025-12-31
-$52.59M
Trailing 12 months to 2026-06-30
2020-12-31: -$45.21M2021-12-31: -$85.93M2022-12-31: -$125.05M2023-12-31: -$103.31M2024-12-31: -$91.53M2025-12-31: -$68.88M-$68.88M
2020-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$68.88Mn/m2026-03-11, From 2025-01-01
2024-12-31-$91.53Mn/m2026-03-11, From 2024-01-01
2023-12-31-$103.31Mn/m2025-03-10, From 2023-01-01
2022-12-31-$125.05Mn/m2024-03-18, From 2022-01-01
2021-12-31-$85.93Mn/m2023-03-08, From 2021-01-01
2020-12-31-$45.21Mn/a2022-03-23, From 2020-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Tenaya Therapeutics, Inc. (TNYA)2025-12-31-$68.88Mn/m
Inhibrx Biosciences, Inc. (INBX)2025-12-31-$129.82Mn/m
Black Diamond Therapeutics, Inc. (BDTX)2024-12-31-$62.30Mn/m
Precision Biosciences Inc (DTIL)2025-12-31-$65.93Mn/m
Compugen Ltd (CGEN)2025-12-31$31.33M-36.7%
Palisade Bio, Inc. (PALI)2024-12-31-$12.19Mn/m
Artiva Biotherapeutics, Inc. (ARTV)2025-12-31-$79.34Mn/m
Cabaletta Bio, Inc. (CABA)2025-12-31-$132.31Mn/m
Pelthos Therapeutics Inc. (PTHS)2025-12-31-$22.69Mn/m

Compare TNYA, INBX, BDTX, DTIL side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗